Christophe JEAN

Co-Founder

Strategic Partner, ORAXYS Private Equity (2019-Present) 

§Senior advisor to the fund and several portfolio companies


Board Member, Various (2018-Present)

§Board membership at Rhythm Pharmaceuticals Inc, B.Cell and KEOSYS Medical imaging


Head of M&A & COO Ipsen (2002-2018)

§Concluded several BD deals & agreements that have enhanced the Ipsen R&D pipeline and commercial portfolio

CEO Pharma, Pierre Fabre Group (2000-2002)

§Responsible for Primary Care, Oncology, OTC and Odontological business with a worldwide turnover of €610mm and 3,700 staf
§Participated in the merger with bioMérieux

VP Finance & IT, Novartis (1997-2000)
 

eureKING

128 rue de la Boétie, 75008 Paris, France

info@eureKING.com

Press Contacts

 

Nicolas Merigeau

+33 (0)1 44 71 94 98 

nmerigeau@newcap.fr 

Arthur Rouillé

+33 (0)1 44 71 00 15

arouille@newcap.fr